Novartis acquires Anthos from Blackstone in the midst of a booming market exit trend
Novartis Acquires Anthos Therapeutics from Blackstone in Mega Exit Surge Novartis, a leading pharmaceutical company, has recently made headlines by acquiring Anthos Therapeutics from Blackstone for a whopping $3.1 billion.
